Evaluation of Suspected Liver Pathology in Patients With Contraindications for Contrast Enhanced Computed Tomography and/or Magnetic Resonance Imaging Using Sonazoid
Withdrawn prior to enrolment
Phase of Trial: Phase III
Latest Information Update: 15 Sep 2017
At a glance
- Drugs Perflubutane (Primary)
- Indications Liver cancer
- Focus Diagnostic use
- 12 Sep 2017 Planned initiation date changed from 1 Mar 2017 to 1 Oct 2017.
- 12 Sep 2017 Status changed from not yet recruiting to withdrawn prior to enrolment.
- 29 Mar 2017 Planned initiation date changed from 1 Mar 2016 to 1 Mar 2017.